Farmacosmo S.p.A.
I · AI Analysis
The brief
Farmacosmo operates as an online retailer of health and pharmacy products, vitamins, skincare, haircare, baby products, and household goods in Italy and the European Union [Yahoo Finance]. The company also provides online psychology and psychotherapy services alongside its e-commerce logistics operations [Yahoo Finance].
Farmacosmo S.p.A. is a Naples-based online retailer selling health, pharmacy, beauty, and household products across Italy and the EU [Yahoo Finance]. The company reported a 34% revenue decline in the first half of 2026 but returned to positive operating margin and EBITDA after losses [Pharmacy Scanner]. With trailing-twelve-month losses, negative free cash flow, and a Health Score of 0.6/10, the financial position carries significant risk [Sentinellis calculation].
The company is unprofitable with negative margins and cash flow, though recent half-year results show improvement.
Sentinellis health
Significant risks
0.6/10
7.5+ strong · 4.5–7.5 moderate · under 4.5 weak
Profitability
Returns on capital
Growth & momentum
Balance sheet
Cash generation
Value creation
Sentinellis calculation from the published statements — not a score reported by any data source. Each category is scored on the checks that had data; missing inputs are excluded rather than counted as failures.
Market capitalisation
EUR 16.3M
Revenue (TTM)
EUR 46.2M
Explainers
How we read these numbers
Plain-English guides · no account needed
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
ReadPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
ReadAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
ReadII · Recent news
What moved
4 stories · ranked by relevance
- Company2026-10-12
Farmacosmo, nel primo semestre torna positivo il margine operativo. Ricavi -34% - Pharmacy Scanner
Pharmacy Scanner
- Company2026-09-28
Farmacosmo, l'EBITDA torna in positivo nel primo semestre - Borsa Italiana
Borsa Italiana
- Company2026-09-28
Conti Farmacosmo, i risultati finanziari dei primi sei mesi del 2026 - SoldiOnline.it
soldionline.it
- Company2026-09-28
Farmacosmo: nel I sem Ebitda torna in positivo, perdita migliora a 0,86 mln -2- - Il Sole 24 ORE
Il Sole 24 ORE
Premium · Free with any account
Revenue declined 33.8% in the latest reported period versus a year earlier, a sharp contraction that raises questions about competitive position and market demand [Yahoo Finance]
Risks
6
Opportunities
4
Red flags
2
Leadership
1
11 more findings in the full report — free with any account.
Unlock the full Farmacosmo S.p.A. analysis
Create a free account to access the complete AI-generated report with inline citations.
- 6 risks, 4 opportunities and 2 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare — or comparable health
Want this for your watchlist?